Analyst Reco. Eli Lilly and Company Wiener Boerse

Equities

LLYC

US5324571083

End-of-day quote Wiener Boerse Other stock markets 06:00:00 2024-06-13 pm EDT			5-day change	1st Jan Change
823.9 ^EUR	+1.08%		+4.81%	+56.04%

Jun. 14	Health Care Slips as Gilead Rallies on Weight-Loss Plans - Health Care Roundup	DJ
Jun. 14	Investors need more time to assess Fed comments

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BIOGEN EXEC SAYS THE ALZHEIMER'S DRUG MARKET "WILL DEVELOP FASTE…	Jun. 12	RE
Social Buzz: Wallstreetbets Stocks Mixed Premarket Wednesday; Oracle to Advance, AST SpaceMobile to Open Lower	Jun. 12	MT
Jefferies Adjusts Price Target on Eli Lilly and Co. to $994 From $957	Jun. 11	MT
Jefferies Adjusts Price Target on Eli Lilly to $957 From $925	Jun. 07	MT
Goldman Sachs Adjusts Price Target on Eli Lilly to $785 From $740	May. 30	MT
Jefferies Adjusts Price Target on Eli Lilly to $925 From $915	May. 23	MT
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell; Hims & Hers Health to Advance, AMC Entertainment to Decline	May. 21	MT
Argus Adjusts Price Target on Eli Lilly to $840 From $770	May. 14	MT
Redburn Atlantic Adjusts Eli Lilly Price Target to $600 From $540	May. 14	MT
China Merchants Initiates Eli Lilly at Buy Rating With $852 Price Target	May. 08	MT
JPMorgan Adjusts Price Target on Eli Lilly to $900 From $850	May. 01	MT
Wolfe Research Adjusts Price Target on Eli Lilly to $909 From $813	May. 01	MT
Barclays Adjusts Price Target on Eli Lilly and Company to $913 From $810	May. 01	MT
BMO Capital Adjusts Eli Lilly Price Target to $1,001 From $900	May. 01	MT
Leerink Partners Adjusts Price Target on Eli Lilly to $901 From $821	May. 01	MT
Deutsche Bank Adjusts Price Target on Eli Lilly to $725 From $695	May. 01	MT
Truist Raises Price Target on Eli Lilly to $892 From $850, Keeps Buy Rating	May. 01	MT
Goldman Sachs Adjusts Price Target on Eli Lilly to $740 From $723	May. 01	MT
Wells Fargo Adjusts Eli Lilly Price Target to $875 From $825	May. 01	MT
Morgan Stanley Raises Price Target on Eli Lilly to $1,023 From $950 Amid 2024 Guidance Boost, Keeps Overweight Rating	May. 01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm EDT